Treating colonic diverticula with rifaximin: a call to action - PubMed

doi: 10.1007/s11739-024-03602-x. Epub 2024 Apr 20.

1. 1. Tursi A, Brandimarte G, Di Mario F, Lanas A, Scarpignato C, Bafutto M, Barbara G, Bassotti G, Binda GA, Biondi A, Biondo S, Cambiè G, Cassieri C, Crucitti A, Dumitrascu DL, Elisei W, Escalante R, Herszènyi L, Kruis W, Kupcinskas J, Lahat A, Lecca PG, Maconi G, Malfertheiner P, Mazzari A, Mearìn F, Milosavljeviċ T, Nardone G, Chavez De Oliveira E, Papa A, Papagrigoriadis S, Pera M, Persiani R, Picchio M, Regula J, Štimac D, Stollman N, Strate LL, Violi A, Walker MM (2019) International consensus on diverticulosis and diverticular disease. statements from the 3rd international symposium on diverticular disease. J Gastrointestin Liver Dis 28:57–66 - DOI - PubMed
2. 1. Tursi A, Scarpignato C, Strate LL, Lanas A, Kruis W, Lahat A, Danese S (2020) Colonic diverticular disease. Erratum. In: Nat Rev Dis Primers. 6(1):20
3. 1. Piccin A, Gulotta M, di Bella S, Martingano P, Crocè LS, Giuffrè M (2023) Diverticular disease and rifaximin: an evidence-based review. Antibiotics (Basel) 12(3):443 - DOI - PubMed
4. 1. Gatta L, Bellini M, Scarpignato C, Marrocco W, Chiriatti A, Grosso A, Lambiase C, Usai-Satta P, Vassallo R, Bartoletti P, Minica F, Manta R, Scotti S, Soncini M (2024) Rifaximin in diverticulosis and diverticular disease: a national survey among Italian gastroenterologists and general practitioners. Intern Emerg Med https://doi.org/10.1007/s11739-024-03597-5
5. 1. Cuomo R, Barbara G, Annibale B (2017) Rifaximin and diverticular disease: position paper of the Italian Society of Gastroenterology (SIGE). Dig Liver Dis 49:595–603 - DOI - PubMed